Proteomic analysis identifies GSN as a non-invasive circulating serum biomarker for predicting early recurrence of hepatocellular carcinoma

Published: 22 December 2023| Version 1 | DOI: 10.17632/kc6mnp6jrw.1
Contributor:
En Hu

Description

The Data for each figure.

Files

Categories

Proteomics, Expression Proteomics

Licence